Exact Sciences planning follow-on

Exact Sciences Corp. (NASDAQ:EXAS) said late Wednesday that it is planning a follow-on underwritten by Jefferies; Baird; Lazard; and Rodman. Further details were not disclosed. Exact is developing its...